Skip to main content

AEROCHAMBER2GO* Chamber

For use with your metered dose inhaler while on the go

Contact a Rep
Buy Online

Why this device?

Proven to deliver medication better than your inhaler alone1 the new AEROCHAMBER2GO* Chamber helps deliver inhaler medication where it is needed to work in your lungs.

Designed and developed with the help of inhaler users, the 2-in-1 chamber also acts as a protective storage case for your inhaler. Ideal for adolescents and adults, the  AEROCHAMBER2GO* Chamber fits most designs of inhalers.

The AEROCHAMBER2GO* Chamber is not designed for use with round mouthpiece inhalers such as Airomir†, Qvar† or Alvesco†. You may also want to consider using an AEROCHAMBER PLUS* FLOW-VU* chamber at home along with your controller medications. Check with your pharmacist to see which is best for you.

1. Suggett et al. Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber. European Respiratory Journal 2019 54:PA4229

  • Asthma Management
  • Bronchiectasis
  • COPD
  • Cystic Fibrosis
  • Inhaler

Product Overview

Why is an inhaler always together with an AEROCHAMBER* spacer?

Use of a spacer is a simple and effective way to help improve the use of your inhaler. Spacers help to ensure that your medicine reaches your lungs where it’s needed and limits the amount that ends up in the back of the throat.2

People who use a valved-holding chamber (VHC) with their inhaler have better control of their respiratory symptoms.3

To improve drug delivery, respiratory guidelines recommend the use of chambers when using metered dose inhalers or puffers in people of all ages.4,5

Compact Design

Lightweight and portable chamber that works with your rescue inhaler

On-the-Go Inhaler Storage

Easy access to your medicine when needed most.

2 McIvor RA et al. Optimizing the delivery of inhaled medication for respiratory patients: the role of valved holding chambers. Canadian Respiratory Journal 2018.

3 Levy ML et al. Asthma patients’ inability to use a pressurized metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J. 2013; Dec;22(4):406-11

4 Canadian Thoracic Society – 2010 Consensus Summary for children six years of age and over, and adults.

5 Global Initiative for Asthma 2020.

Reimbursement Information

Care Instructions

How to Use an AEROCHAMBER2GO* Chamber

Follow these simple instructions or download our full instructions

  • Aerochamber2go how to use, step 1 -Remove cap from inhaler

    Step 1:

    Shake the inhaler immediately before use (remove cap)

How to Clean an AEROCHAMBER2GO* Chamber

Follow these simple instructions or download our full instructions.

Data and Efficacy

Scientific and Performance Evidence

  • Patient centered development of the AEROCHAMBER2GO* device

    Patients were actively involved in all stages of the development process including: understanding the patient needs and therefore problems to solve, interactive involvement in concept development, feedback on functionality and appearance, and handling / usability.

    Download
  • Patients preferred compared to other portable spacer devices

    Device preference study showed the AEROCHAMBER2GO* prototype was preferred by patients compared to the A2A spacer and that patients were very likely to use while on-the-go.

    Download
  • Evaluation of the AEROCHAMBER2GO* device with Zenhale† MDI

    This laboratory study evaluated the medication delivery performance when using a LABA (Formoterol) containing combination MDI with and without a new portable AEROCHAMBER2GO* 2 in 1 chamber and protective case.

    Download
  • Laboratory evaluation of the AEROCHAMBER2GO* device use with Foster† MDI

    The AEROCHAMBER2GO* 2 in 1 chamber and protective case delivered similar fine particle delivery after a simulated 2-second delay to the Foster MDI alone, when the pMDI alone was tested with simulated perfect technique (no delay). In addition, the large particles that could be deposited in the oropharynx and potentially lead to side effects were reduced more than ten fold when using the AEROCHAMBER2GO* device compared to the MDI alone.

    Download
  • Delivery comparable to the established AEROCHAMBER PLUS* FLOW-VU* chamber

    Based on findings from this laboratory study, both the AEROCHAMBER2GO* device and AEROCHAMBER PLUS* FLOW-VU* chamber deliver similar amounts of salbutamol to the lungs. The valved spacers also provide the additional benefit of reduced oropharyngeal deposition compared to the MDI when used alone.

    Download
  • Improved adherence and high patient satisfaction with AEROCHAMBER2GO* device

    This initial post launch survey highlighted a substantial increase in use of spacers with pMDIs while ‘On the go’. The spacer’s improved ease of use, carrying and appearance may well have contributed to the noted increased adherence. Use of AEROCHAMBER2GO* spacer should be considered for all patients requiring a reliever pMDI when ‘On the go’

    Download

FAQs